Simple financial analysis & investment research


Merck Financials Q4 2013

by March 11, 2014
Merck Financials Q4 2013

Charts for: – sales, costs, margins, earnings – current assets, long-term assets, liabilities, debt, equity – cash flows from operations,…


Merck Financials Q3 2013

· by November 12, 2013
Merck Financials Q3 2013

Merck (MRK): A little growth pill wouldn’t hurt the declining sales.
At least the cash flows from operating activities look healthy.


Merck Complete Financials Q2 2013

· by August 14, 2013
Merck Complete Financials Q2 2013

Merck Complete Financials Q2 2013.
The original MRK report for Q2 2013 is being updated here.
Conclusions are the same: sales declining, costs increasing, earnings down.
Pipeline is drying.


Merck Financials Q2 2013

· by August 5, 2013
Merck Financials Q2 2013

Merck Q2 2013: sales declining, costs increasing, earnings down.